US 10307481
CD37 immunotherapeutics and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10307481 (CD37 immunotherapeutics and uses thereof) held by Aptevo Research and Development LLC expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptevo Research and Development LLC
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955